Find latest DLBCL videos · 200+ videos
G

Managing R/R DLBCL: Bispecific Antibodies and the "Surface Epitopes Strategy"

By Gerardo Musuraca 4 Videos
79 views
June 17, 2024
Comments 0
Login to view comments. Click here to Login

Related Videos

Penn Medicine Abramson Cancer Center

Cellicon Valley '25: The Future of Cell and Gene Therapies

Wed, Apr 30, 2025
16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.7K views
33:01

2024 Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

348 views
33:46

ASH 2024 Review: Key Updates in Non-Hodgkin Lymphoma

Cleveland Clinic Taussig Cancer Institute

P. Caimi

191 views
11:49

New

ASH 2025 Review: Updates in Frontline & R/R DLBCL

University of Colorado Division of Hematology

M. Kamdar

125 views
22:14

Treating Patients With DLBCL Who Are Not Eligible for CAR-T Therapy

Remy Dulery

244 views
10:27

Sequencing Cellular Therapy and Bispecific Antibodies in DLBCL

Megan Melody

210 views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

481 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

584 views
09:17

ASH 2024 Insights: Outcomes With Bispecific Antibodies Post-CAR T-Ce…

2024 ASH Annual Meeting Insights Hub

M. Melody

169 views
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

605 views
11:43

Updates on Approved CAR-Ts for Lymphomas

Moffitt Cancer Center

J. Chavez

128 views
10:09

Tafasitamab + Lenalidomide in R/R DLBCL: Updated Results From the L-…

David Bond

143 views
11:50

Infectious Disease Perspective of CAR T-Cell Therapy

Moffitt Cancer Center

A. Baluch

109 views
22:35

Lymphoma Hot Topics in 2024: Focus on DLBCL and cHL

Yale Cancer Center

T. Sethi

228 views
07:57

New

ASH 2024 Insights: Timing of CAR-T Failure as a Predictor of Outcome…

2024 ASH Annual Meeting Insights Hub

E. Shumilov

91 views
13:58

Managing R/R LBCL Patients Treated With Pola-R-CHP in 1L and Are CAR…

University of Colorado Cancer Center

M. Kamdar

142 views
20:34

Sequencing of Bispecifics With Other Therapies in DLBCL

UChicago Medicine

E. Budde

456 views
08:49

ASH 2024 Insights: Odronextamab in R/R DLBCL Post-CAR T-Cell Progres…

2024 ASH Annual Meeting Insights Hub

M. Matasar

112 views
06:07

Tafasitamab + Lenalidomide vs. CIT for Transplant-Ineligible R/R DLB…

Patrizia Mondello

234 views
13:07

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Moffitt Cancer Center

J. Chavez

923 views
AUTOPLAY